Multicenter comparison of imprecision at low concentrations of two regulatory approved high-sensitivity cardiac troponin I assays.

[1]  B. Lindahl,et al.  High-Sensitivity Cardiac Troponin-Based Strategies for the Assessment of Chest Pain Patients-A Review of Validation and Clinical Implementation Studies. , 2018, Clinical chemistry.

[2]  P. Kavsak.  External Quality Assessment Testing Near the Limit of Detection for High-Sensitivity Cardiac Troponin Assays. , 2018, Clinical chemistry.

[3]  P. Kavsak,et al.  Assessing matrix, interferences and comparability between the Abbott Diagnostics and the Beckman Coulter high-sensitivity cardiac troponin I assays , 2018, Clinical chemistry and laboratory medicine.

[4]  Tony Badrick,et al.  The importance of low level QC for high sensitivity troponin assays. , 2018, Clinical biochemistry.

[5]  A. Jaffe,et al.  Variability Between Reagent Lots for High-Sensitivity Cardiac Troponin I May Affect Performance of Early Rule Out Strategies. , 2017, The Canadian journal of cardiology.

[6]  Dina N. Greene,et al.  Total Analytic Error for Low Cardiac Troponin Concentrations (≤10 ng/L) by Use of a High-Sensitivity Cardiac Troponin Assay. , 2017, Clinical chemistry.

[7]  A. Lyon,et al.  Simulation Models of Misclassification Error for Single Thresholds of High-Sensitivity Cardiac Troponin I Due to Assay Bias and Imprecision. , 2017, Clinical chemistry.

[8]  P. Kavsak,et al.  Acceptable Analytical Variation May Exceed High-Sensitivity Cardiac Troponin I Cutoffs in Early Rule-Out and Rule-In Acute Myocardial Infarction Algorithms. , 2016, Clinical chemistry.

[9]  P. Kavsak,et al.  A practical approach for the validation and clinical implementation of a high-sensitivity cardiac troponin I assay across a North American city , 2015, Practical laboratory medicine.

[10]  P. Kavsak,et al.  Centrifugation--an important pre-analytical factor for the Abbott Architect high-sensitivity cardiac troponin I assay. , 2014, Clinica chimica acta; international journal of clinical chemistry.